Zika Vaccine Candidate Shows Promise in Phase 1 Trial Zika Vaccine Candidate Shows Promise in Phase 1 Trial

A Zika virus vaccine candidate prompted antibody responses in 80% of individuals who received two doses in a phase 1 study.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news